Literature DB >> 1446860

IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.

L Helgeland1, C Tysk, G Järnerot, K Kett, E Lindberg, D Danielsson, S N Andersen, P Brandtzaeg.   

Abstract

Serum samples from 26 monozygotic twin pairs concordant or discordant with regard to inflammatory bowel disease, and rectal biopsies from 42 twins of the same subject group, were examined for IgG subclasses. They were all compared with normal controls. Almost all affected twins were in clinical remission. Paired immunofluorescence staining of the rectal mucosa showed that those with ulcerative colitis had a significantly higher (p < 0.01) proportion of IgG1 producing mucosal immunocytes than normal controls (78.1% v 55.9%). Conversely, the IgG2 cell fraction was significantly reduced (15.9% v 34.6%). Healthy twins from ulcerative colitis pairs tended to show a raised proportion of IgG1 cells and the IgG2 cell fraction was significantly reduced (p < 0.05). In discordant ulcerative colitis twin pairs, no difference appeared in the cellular IgG subclass pattern between healthy and affected twins. Furthermore, the proportion of IgG1 in these healthy and diseased twins showed good correlation (T = 0.867). The results in rectal mucosa of twins with Crohn's disease were widely scattered and affected twins did not differ significantly from normal controls. Healthy twins, however, showed a marginally raised IgG1 cell proportion, but no correlation was seen between the IgG subclass fractions in discordant Crohn's disease twin pairs. The serum concentrations of IgG1 and IgG2 did not differ from normal controls in twins of either category. These results suggested that in ulcerative colitis, the aberrant mucosal production of IgG1 and IgG2 does not depend on active disease, but is apparently at least partially explained by a genetic impact. Conversely, the mucosal IgG subclass pattern in Crohn's disease appears to be determined mainly by exogenous variables.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446860      PMCID: PMC1379604          DOI: 10.1136/gut.33.10.1358

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Studies on similarity diagnosis in twins with the aid of mailed questionnaires.

Authors:  R CEDERLOF; L FRIBERG; E JONSSON; L KAIJ
Journal:  Acta Genet Stat Med       Date:  1961

3.  The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration.

Authors:  P Garred; T E Michaelsen; A Aase
Journal:  Scand J Immunol       Date:  1989-09       Impact factor: 3.487

4.  One allele [G2m(n)] of the human IgG2 locus is more productive than the other.

Authors:  N Rautonen; H Sarvas; O Mäkelä
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

5.  Antibody response to anaerobic coccoid rods in Crohn's disease.

Authors:  K Bull; N Matthews; J Rhodes
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

6.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

Authors:  C Tysk; E Lindberg; G Järnerot; B Flodérus-Myrhed
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

7.  Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease.

Authors:  R Paganelli; F Pallone; S Montano; S Le Moli; P M Matricardi; S Fais; P Paoluzi; R D'Amelio; F Aiuti
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

8.  IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n).

Authors:  H Sarvas; N Rautonen; S Sipinen; O Mäkelä
Journal:  Scand J Immunol       Date:  1989-02       Impact factor: 3.487

9.  Genetic markers and inflammatory bowel disease: immunoglobulin allotypes (GM, KM) and protease inhibitor.

Authors:  L L Field; N Boyd; T J Bowen; J K Kelly; L R Sutherland
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

10.  Ig allotype-linked regulation of class and subclass composition of natural antibodies to group A streptococcal carbohydrate.

Authors:  A Morell; G Vassalli; G G DeLange; F Skvaril; D M Ambrosino; G R Siber
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

View more
  10 in total

1.  Elevated basal intestinal mucosal cytokine levels in asymptomatic first-degree relatives of patients with Crohn's disease.

Authors:  Anant VK Indaram; Santa Nandi; Sam Weissman; Sing Lam; Beverly Bailey; Meyer Blumstein; Ronald Greenberg; Simmy Bank
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Circulating immunoglobulin G1 antibody in patients with ulcerative colitis against the colonic epithelial protein detected by a novel monoclonal antibody.

Authors:  A Dasgupta; A Mandal; K M Das
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

Review 3.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

4.  P-ANCA in monozygotic twins with inflammatory bowel disease.

Authors:  P Yang; G Järnerot; D Danielsson; C Tysk; E Lindberg
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

5.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

Review 6.  Current concepts of the pathogenesis of inflammatory bowel disease.

Authors:  F Shanahan
Journal:  Ir J Med Sci       Date:  1994-12       Impact factor: 1.568

7.  Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.

Authors:  D Aldebert; E Masy; D Reumaux; G Lion; J F Colombel; P Duthilleul
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

8.  Biased JH usage in plasma cell immunoglobulin gene sequences from colonic mucosa in ulcerative colitis but not in Crohn's disease.

Authors:  D K Dunn-Walters; L Boursier; M Hackett; J Spencer
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

Review 9.  B cell class switching in intestinal immunity in health and disease.

Authors:  Aaron Fleming; Tomas Castro-Dopico; Menna R Clatworthy
Journal:  Scand J Immunol       Date:  2022-01-12       Impact factor: 3.889

Review 10.  The B-cell system of human mucosae and exocrine glands.

Authors:  P Brandtzaeg; I N Farstad; F E Johansen; H C Morton; I N Norderhaug; T Yamanaka
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.